Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-02-20
DOI
10.1002/ajh.25444
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials
- (2018) James Bussel et al. AMERICAN JOURNAL OF HEMATOLOGY
- Splenectomy for immune thrombocytopenia: down but not out
- (2018) Shruti Chaturvedi et al. BLOOD
- A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP
- (2018) Francesco Rodeghiero BRITISH JOURNAL OF HAEMATOLOGY
- Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response
- (2017) Miriam Marangon et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
- (2017) Anne Zufferey et al. Journal of Clinical Medicine
- Gender and duration of disease differentiate responses to rituximab-dexamethasone therapy in adults with immune thrombocytopenia
- (2016) John Chapin et al. AMERICAN JOURNAL OF HEMATOLOGY
- The Novel Oral Syk Inhibitor, Bl1002494, Protects Mice From Arterial Thrombosis and Thromboinflammatory Brain InfarctionHighlights
- (2016) Judith M.M. van Eeuwijk et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia
- (2013) S. Boyle et al. BLOOD
- Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia
- (2012) Francesco Zaja et al. AMERICAN JOURNAL OF HEMATOLOGY
- Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
- (2012) V. L. Patel et al. BLOOD
- Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years
- (2012) N. Vianelli et al. HAEMATOLOGICA
- Syk-dependent signaling pathways in neutrophils and macrophages are indispensable in the pathogenesis of anti-collagen antibody-induced arthritis
- (2012) N. Ozaki et al. INTERNATIONAL IMMUNOLOGY
- Critical role for Syk in responses to vascular injury
- (2011) P. Andre et al. BLOOD
- The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports
- (2009) Deirdra R. Terrell et al. AMERICAN JOURNAL OF HEMATOLOGY
- Immune thrombocytopenic purpura: epidemiology and implications for patients
- (2009) Marc Michel EUROPEAN JOURNAL OF HAEMATOLOGY
- Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
- (2009) James B Bussel et al. LANCET
- Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk
- (2008) A. Podolanczuk et al. BLOOD
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
- (2008) F. Rodeghiero et al. BLOOD
- Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
- (2008) David J Kuter et al. LANCET
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now